Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
Int J Cardiol
    December 2025
  1. ATIF MM, Lohano G, Ram M, Irshad NUN, et al
    Letter to the editor: Outcomes in patients undergoing trans-catheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025;440:133699.
    >> Share

  2. PANG X, Zhao S, Zhang F
    Comment on: "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population".
    Int J Cardiol. 2025;440:133698.
    >> Share

    November 2025
  3. TAKAGI R, Kobayashi M, Kuwahara A, Takihara K, et al
    Trajectory, correlates, and outcomes of pulmonary congestion by lung ultrasound in patients hospitalized for acute pulmonary edema.
    Int J Cardiol. 2025;438:133599.
    >> Share

  4. ZAMORANO JL, Voros G, Calvi V, Osca J, et al
    Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial.
    Int J Cardiol. 2025;438:133526.
    >> Share

  5. LANG Z, Girerd N, Zhang H, Xu H, et al
    Validation of a noninvasive device for measuring filling pressure against invasive pulmonary capillary wedge pressure.
    Int J Cardiol. 2025;438:133479.
    >> Share

    September 2025
  6. VAN ESSEN BJ, Dan NAE, Tharsana GN, Kaur P, et al
    Obesity and inactivity cluster the strongest risk factor for the development of heart failure in a population-based study.
    Int J Cardiol. 2025 Sep 19:133914. doi: 10.1016/j.ijcard.2025.133914.
    >> Share

  7. REN JM, Wang YG, Zheng JL, Wang WY, et al
    Reply to "Reconsidering thyroid hormone assessment in heart failure risk prediction".
    Int J Cardiol. 2025 Sep 16:133912. doi: 10.1016/j.ijcard.2025.133912.
    >> Share

  8. ALAWAJNEH MM, Aljabali A, Theeb L, Tashtoush S, et al
    Predictors of discontinuation and non-publication of heart failure clinical trials: A cross-sectional analysis of ClinicalTrials.gov data.
    Int J Cardiol. 2025;442:133901.
    >> Share

  9. LI L
    Re-evaluating composite CRP-based ratios in chronic heart failure: clarity beyond novelty.
    Int J Cardiol. 2025 Sep 12:133899. doi: 10.1016/j.ijcard.2025.133899.
    >> Share

  10. CHEN X, Zhang Q, Bao Y
    Reconsidering thyroid hormone assessment in heart failure risk prediction.
    Int J Cardiol. 2025 Sep 8:133872. doi: 10.1016/j.ijcard.2025.133872.
    >> Share

  11. UMAR M, Zaheer M, Gillani Z
    Letter to the Editor: Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure.
    Int J Cardiol. 2025 Sep 6:133871. doi: 10.1016/j.ijcard.2025.133871.
    >> Share

  12. RANA AM, Rafay MA, Amjad MW, Aslam MH, et al
    Critical appraisal of early diagnosis and progression to heart failure with preserved ejection fraction among hypertensive patients with left ventricular hypertrophy.
    Int J Cardiol. 2025 Sep 6:133877. doi: 10.1016/j.ijcard.2025.133877.
    >> Share

  13. ABOU KAMAR S, van Ommen AM, Dal Canto E, Valstar G, et al
    The plasma proteome is linked to echocardiographic parameters and stages of diastolic dysfunction, across the ejection fraction spectrum.
    Int J Cardiol. 2025;434:133329.
    >> Share

    August 2025
  14. NOIRI JI, Tanaka H
    Authors' reply to Zhang et al. regarding "Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population".
    Int J Cardiol. 2025 Aug 28:133840. doi: 10.1016/j.ijcard.2025.133840.
    >> Share

  15. ZHANG L, Luo Z, Lin R
    Comment on "Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population".
    Int J Cardiol. 2025 Aug 28:133841. doi: 10.1016/j.ijcard.2025.133841.
    >> Share

  16. MONZO L, Girerd N
    Decoding the inflammatory-metabolic code: machine learning potential for outcome prediction in heart failure with diabetes.
    Int J Cardiol. 2025 Aug 27:133828. doi: 10.1016/j.ijcard.2025.133828.
    >> Share

  17. MEGHWAR S, Bhagwan R, Naqvi SMM, Wali F, et al
    Trends in heart failure-related mortality among psychoactive drug users in the United States: A nationwide cross-sectional analysis of the CDC WONDER database.
    Int J Cardiol. 2025;441:133790.
    >> Share

  18. PALM CL, de Wit S, Gorter TM, Rienstra M, et al
    Reply to Letter to the Editor: Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failure.
    Int J Cardiol. 2025 Aug 19:133809. doi: 10.1016/j.ijcard.2025.133809.
    >> Share

  19. NOIRI JI, Tanaka H
    Authors' reply to Wang on frailty dynamics and implementation in super aged heart failure.
    Int J Cardiol. 2025 Aug 18:133799. doi: 10.1016/j.ijcard.2025.133799.
    >> Share

  20. REN JM, Wang YG, Zheng JL, Wang WY, et al
    Thyroid hormones were associated with incident heart failure subtypes and changes in cardiac structure and function: results from the atherosclerosis risk in communities study.
    Int J Cardiol. 2025;441:133794.
    >> Share

  21. BARACCHINI N, Capovilla TM, Rossi M, Carriere C, et al
    Unveiling the limitations of non-metabolic thresholds in assessing maximal effort: The role of cardiopulmonary exercise testing.
    Int J Cardiol. 2025;433:133292.
    >> Share

  22. CARLUCCIO E, Fortuni F, Ambrosio G
    Don't stop now: The imperative to maintain SGLT2 inhibitors in older patients with heart failure.
    Int J Cardiol. 2025;441:133775.
    >> Share

  23. NOIRI JI, Tanaka H
    Authors' reply to Wang et al. regarding "Efficacy of sodium glucose cotransporter 2 inhibitors for super aged heart failure population".
    Int J Cardiol. 2025 Aug 12:133782. doi: 10.1016/j.ijcard.2025.133782.
    >> Share

  24. NOIRI JI, Tanaka H
    Authors' reply to Hong et al. regarding "Efficacy of sodium glucose cotransporter 2 inhibitors for super aged heart failure population".
    Int J Cardiol. 2025 Aug 12:133783. doi: 10.1016/j.ijcard.2025.133783.
    >> Share

  25. WANG Y
    Optimizing SGLT2 inhibitor continuation in super-aged heart failure.
    Int J Cardiol. 2025 Aug 9:133759. doi: 10.1016/j.ijcard.2025.133759.
    >> Share

  26. ZHU Y, Guo J
    Omics-driven strategy develops a tumor biomarker-derived signature to forecast the occurrence and progression of heart failure.
    Int J Cardiol. 2025 Aug 9:133742. doi: 10.1016/j.ijcard.2025.133742.
    >> Share

  27. HU Y, Zhang Y, Han P, Pan Y, et al
    Machine learning-driven prediction of readmission risk in heart failure patients with diabetes: synergistic assessment of inflammatory and metabolic biomarkers.
    Int J Cardiol. 2025;441:133743.
    >> Share

  28. HONG F, Sun B
    Comment on efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population.
    Int J Cardiol. 2025 Aug 7:133739. doi: 10.1016/j.ijcard.2025.133739.
    >> Share

  29. ZHU B, Xu Y
    Expanding generalizability and addressing bias in mobile app-assisted heart failure screening.
    Int J Cardiol. 2025 Aug 7:133738. doi: 10.1016/j.ijcard.2025.133738.
    >> Share

  30. HASUMI E, Fujiu K
    Reply to "Comments: Heart failure monitoring with a single-lead electrocardiogram at home".
    Int J Cardiol. 2025 Aug 6:133734. doi: 10.1016/j.ijcard.2025.133734.
    >> Share

  31. WANG K, Gao W
    Letter to "efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population".
    Int J Cardiol. 2025 Aug 4:133712. doi: 10.1016/j.ijcard.2025.133712.
    >> Share

  32. WANG B
    Letter to the Editor: Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Aug 4:133701. doi: 10.1016/j.ijcard.2025.133701.
    >> Share

  33. HUANG Z, Pan L, Xiao Z, Rao F, et al
    Kirenol attenuates pressure overload-induced heart failure by enhancing autophagy in macrophages.
    Int J Cardiol. 2025;440:133681.
    >> Share

  34. GHANI AI, Rehman A, Kazi ZA
    Letter to the Editor: Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failure.
    Int J Cardiol. 2025 Aug 2:133715. doi: 10.1016/j.ijcard.2025.133715.
    >> Share

  35. KASSAB VP, Oldra LGO, Milanesi GS, Souza FR, et al
    Evaluation of early diagnosis and progression to heart failure with preserved ejection fraction: A retrospective study in patients with arterial hypertension and left ventricular hypertrophy.
    Int J Cardiol. 2025 Aug 1:133672. doi: 10.1016/j.ijcard.2025.133672.
    >> Share

  36. AAMIR M, Bilquees A, Saleem D
    Addressing confounding factors in TEER outcomes: A call for deeper analysis [Re: Meulengracht et al., International Journal of Cardiology 439 (2025) 133605 - "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared t
    Int J Cardiol. 2025 Aug 1:133702. doi: 10.1016/j.ijcard.2025.133702.
    >> Share

    July 2025
  37. SCHUPP T, Akin I, Behnes M
    Response to Letter by Dong et al.: BMI and heart failure readmission risk: Rethinking obesity assessment.
    Int J Cardiol. 2025;439:133673.
    >> Share

  38. YADAV A, Yadav O, Gupta N, Gupta R, et al
    Comments: Heart failure monitoring with a single?lead electrocardiogram at home.
    Int J Cardiol. 2025;439:133659.
    >> Share

  39. DONG C, Cui Y, Sima M, Yue D, et al
    Letter regarding the study by Kuhn et al. on BMI and heart failure readmission risk: Rethinking obesity assessment.
    Int J Cardiol. 2025;439:133656.
    >> Share

  40. PAN Z, Liu R, Wang H
    Clarifying the clinical utility of serum DKK1 as a biomarker in PH-related right heart failure.
    Int J Cardiol. 2025 Jul 22:133661. doi: 10.1016/j.ijcard.2025.133661.
    >> Share

  41. STEFANOVIC M, Trifunovic-Zamaklar D, Mladenovic Z, Tadic S, et al
    Utility of Mobile phone app-assisted screening for heart failure in primary care: Insights from the ECHOS3 registry.
    Int J Cardiol. 2025 Jul 22:133651. doi: 10.1016/j.ijcard.2025.133651.
    >> Share

  42. ZEB MU, Atta A
    Letter to the editor: Real-world challenges for guideline-directed medical therapy intolerance in heart failure: A single-center prospective cohort study.
    Int J Cardiol. 2025 Jul 21:133652. doi: 10.1016/j.ijcard.2025.133652.
    >> Share

  43. NOIRI JI, Tanaka H, Odajima S, Fujimoto W, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population.
    Int J Cardiol. 2025;439:133647.
    >> Share

  44. GAO S, Yan Y, Liu L
    Navigating pharmacotherapy in heart failure complicated by atrial fibrillation: A practical summary.
    Int J Cardiol. 2025;439:133640.
    >> Share

  45. VENNER MFGHM, Gevers TJG, Ploum F, Habets J, et al
    Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation.
    Int J Cardiol. 2025;431:133226.
    >> Share

  46. PAGNESI M, Adamo M
    Reply to letter: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025;439:133611.
    >> Share

  47. MEULENGRACHT DE, Petersen JK, Veien KT, de Backer O, et al
    Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Jul 7:133605. doi: 10.1016/j.ijcard.2025.133605.
    >> Share

  48. DUHAN S, Kurpad KP, Keisham B, Shtembari J, et al
    GLP-1RA versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: An updated meta-analysis of randomized controlled trials.
    Int J Cardiol. 2025;438:133604.
    >> Share

  49. ESTLER B, Frohlich H, Tager T, Hund H, et al
    Endothelial dysfunction assessed by the endothelial activation and stress index (EASIX) predicts risk of mortality in chronic heart failure patients.
    Int J Cardiol. 2025;438:133566.
    >> Share

  50. KAMAR SA, van Ommen AM, Canto ED, van Dalen BM, et al
    Reply to 'unveiling the link between plasma proteome and cardiac function: A leap forward in heart failure research'.
    Int J Cardiol. 2025 Jul 1:133576. doi: 10.1016/j.ijcard.2025.133576.
    >> Share

    June 2025
  51. SONG Y, Ma F, Bao X, Liu Y, et al
    Letter to editor: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Jun 25:133560. doi: 10.1016/j.ijcard.2025.133560.
    >> Share

  52. PONTIROLI AE, Ambrosio G, Leoni O, Forlani M, et al
    Reply to letter to the editor: "Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection", by Dr. Mehta and Dr. Sah.
    Int J Cardiol. 2025 Jun 25:133557. doi: 10.1016/j.ijcard.2025.133557.
    >> Share

  53. MANN C, Braunwald E, Zelniker TA
    Diabetic cardiomyopathy revisited: The interplay between diabetes and heart failure.
    Int J Cardiol. 2025 Jun 24:133554. doi: 10.1016/j.ijcard.2025.133554.
    >> Share

  54. MERT GO, Spartalis M, Murat S, Gorenek B, et al
    Commentary on ventricular arrhythmias in acute heart failure: Critical insights into the 2024 ESC-EHRA-ACVC-HFA consensus.
    Int J Cardiol. 2025 Jun 24:133544. doi: 10.1016/j.ijcard.2025.133544.
    >> Share

  55. LAVA SAG
    SGLT2 inhibitors for paediatric heart failure: time for innovative trials.
    Int J Cardiol. 2025;438:133521.
    >> Share

  56. KUMAR SS, Gopalakrishnan A, Krishnamoorthy KM, Sivadasanpillai H, et al
    Reply to comment on "The efficacy and safety of dapagliflozin in pediatric heart failure".
    Int J Cardiol. 2025;438:133547.
    >> Share

  57. SONG Y, Shi Q, Xu C
    Comment on "The efficacy and safety of dapagliflozin in pediatric heart failure".
    Int J Cardiol. 2025 Jun 18:133537. doi: 10.1016/j.ijcard.2025.133537.
    >> Share

  58. KUMAR SS, Gopalakrishnan A, Krishnamoorthy KM, Sivadasanpillai H, et al
    Reply to "the efficacy and safety of dapagliflozin in pediatric heart failure: Interpreting causality in clinical outcomes".
    Int J Cardiol. 2025 Jun 17:133525. doi: 10.1016/j.ijcard.2025.133525.
    >> Share

  59. MEHTA R, Sah R
    Letter to the editor: "Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection".
    Int J Cardiol. 2025 Jun 17:133535. doi: 10.1016/j.ijcard.2025.133535.
    >> Share

  60. D'ELIA E, Zucchetti O, Pedrazzoli F, Cereda A, et al
    Assessing palliative care needs in worsening heart failure patients: Insights from OPPORTUNITIES registry.
    Int J Cardiol. 2025;437:133491.
    >> Share

  61. CEN K, Ahmedy F, Marcus M, Shukor MF, et al
    The efficacy and safety of dapagliflozin in pediatric heart failure: Interpreting causality in clinical outcomes.
    Int J Cardiol. 2025 Jun 10:133499. doi: 10.1016/j.ijcard.2025.133499.
    >> Share

  62. PONTIROLI AE, Ambrosio G, Leoni O, Forlani M, et al
    Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection.
    Int J Cardiol. 2025 Jun 7:133492. doi: 10.1016/j.ijcard.2025.133492.
    >> Share

  63. WANG Z, Wang Q, Xu H, Zhang H, et al
    Pulmonary hypertension induced right heart failure via upregulation of serum Dickkopf-1 expression.
    Int J Cardiol. 2025;437:133481.
    >> Share

  64. KARSTEN M, Palermo P, Mattavelli I, Contini M, et al
    Temporal behavior of exercise oscillatory ventilation and respiratory muscle performance in patients with heart failure.
    Int J Cardiol. 2025;437:133475.
    >> Share

    May 2025
  65. SONG Y, Li M, Zhang Z
    Comment on "impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes".
    Int J Cardiol. 2025 May 27:133441. doi: 10.1016/j.ijcard.2025.133441.
    >> Share

  66. YE Y, Shao WW, Yang C
    Unveiling the link between plasma proteome and cardiac function: A leap forward in heart failure research.
    Int J Cardiol. 2025 May 27:133438. doi: 10.1016/j.ijcard.2025.133438.
    >> Share

  67. MARTINEZ-SELLES M, Vicent L
    Reply to "Sex and clinical outcomes in new-onset heart failure".
    Int J Cardiol. 2025;435:133419.
    >> Share

  68. KUMAR SS, Gopalakrishnan A, Krishnamoorthy KM, Naik S, et al
    The efficacy and safety of dapagliflozin in pediatric heart failure.
    Int J Cardiol. 2025;435:133384.
    >> Share

  69. CUTHBERT JJ, Lomax S, Soyiri I, Luo E, et al
    Loop diuretics, heart failure diagnosis and outcome in primary care.
    Int J Cardiol. 2025 May 18:133386. doi: 10.1016/j.ijcard.2025.133386.
    >> Share

  70. HARADA M, Motoike Y, Nomura Y, Nishimura A, et al
    Response to SGLT2 inhibitors: A potential therapeutic strategy for atrial fibrillation in pulmonary arterial hypertension-induced right heart failure?
    Int J Cardiol. 2025 May 15:133396. doi: 10.1016/j.ijcard.2025.133396.
    >> Share

  71. SALEEM D, Aamir M, Bilquees A
    Evaluating AI consistency in heart failure patient communication: A multidisciplinary critique.
    Int J Cardiol. 2025 May 11:133373. doi: 10.1016/j.ijcard.2025.133373.
    >> Share

  72. CHEN J, Xiao R, Gao L, Zhou Y, et al
    Real-world challenges for guideline-directed medical therapy intolerance in heart failure: A single-center prospective cohort study.
    Int J Cardiol. 2025 May 11:133367. doi: 10.1016/j.ijcard.2025.133367.
    >> Share

  73. TUKKER M, Te Rijdt WP, Amin AS, Morris-Rosendahl DJ, et al
    High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: A multicenter cohort study and review of the literature.
    Int J Cardiol. 2025 May 6:133350. doi: 10.1016/j.ijcard.2025.133350.
    >> Share

  74. KANI R, Miyamoto Y, Saito T, Watanabe A, et al
    Racial and regional differences in efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes: A systematic review and meta-analysis.
    Int J Cardiol. 2025;426:133079.
    >> Share

    April 2025
  75. YAO L, Li H, Luo S, Hao K, et al
    The miR-137/DEL-1 axis-induced apoptosis as a potential heart failure mechanism.
    Int J Cardiol. 2025 Apr 24:133308. doi: 10.1016/j.ijcard.2025.133308.
    >> Share

  76. VERDOIA M, Nardin M, Rognoni A
    Obesity and heart failure: Overcoming the paradox.
    Int J Cardiol. 2025;433:133304.
    >> Share

  77. TRIMARCHI G, Pizzino F, Paradossi U
    Inflammation in chronic heart failure: An unsolved puzzle.
    Int J Cardiol. 2025 Apr 16:133281. doi: 10.1016/j.ijcard.2025.133281.
    >> Share

  78. HASUMI E, Fujiu K, Chen Y, Miyamoto S, et al
    Heart failure monitoring with a single?lead electrocardiogram at home.
    Int J Cardiol. 2025 Apr 8:133203. doi: 10.1016/j.ijcard.2025.133203.
    >> Share

  79. ZHANG Y, Yin X, Zhu H, Shen C, et al
    Letter to the Editor: Sex and clinical outcomes in new-onset heart failure.
    Int J Cardiol. 2025;431:133241.
    >> Share

    March 2025
  80. FAN ZX, Wu JC, Yang J
    SGLT2 inhibitors: A potential therapeutic strategy for atrial fibrillation in pulmonary arterial hypertension-induced right heart failure?
    Int J Cardiol. 2025;430:133206.
    >> Share

  81. RODRIGUES MM, Falcao LM
    Pathophysiology of heart failure with preserved ejection fraction in overweight and obesity - Clinical and treatment implications.
    Int J Cardiol. 2025 Mar 20:133182. doi: 10.1016/j.ijcard.2025.133182.
    >> Share

  82. MOHAMED AA, Christensen DM, Mohammad M, Gluud LL, et al
    The prognostic role of Fibrosis-4 score in heart failure with reduced ejection fraction.
    Int J Cardiol. 2025;429:133174.
    >> Share

  83. KURODA S, Kawamura I, Sahashi Y, Tonegawa-Kuji R, et al
    Effectiveness of rate-adaptive pacing on patients with chronotropic incompetence: Systematic review and meta-analysis of randomized controlled trials.
    Int J Cardiol. 2025;423:133022.
    >> Share

  84. GODINO C, Nemola G, Sisinni A, Margonato D, et al
    Therapeutical approach of tricuspid regurgitation and right heart failure.
    Int J Cardiol. 2025;429:133163.
    >> Share

  85. SZYMCZAK A, Skwarek-Dziekanowska A, Sobieszek G, Malecka-Massalska T, et al
    Comparison of the clinical value of inflammatory blood biomarkers in relation to disease severity and survival in chronic heart failure.
    Int J Cardiol. 2025;429:133165.
    >> Share

  86. KESSLER EL, Dal Canto E, Diez-Benavente E, van Ommen AM, et al
    Non-classical monocytes are associated with functional markers of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction.
    Int J Cardiol. 2025;429:133161.
    >> Share

  87. PEIRO OM, Bardaji A, Carrasquer A, Cediel G, et al
    Growth differentiation factor 15: A biomarker to guide empagliflozin treatment in acute myocardial infarction?
    Int J Cardiol. 2025;429:133167.
    >> Share

  88. PALM CL, de Wit S, Gorter TM, Rienstra M, et al
    Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failure.
    Int J Cardiol. 2025;428:133124.
    >> Share

  89. PANCALDI E, Adamo M, Pagnesi M, Russo G, et al
    Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Mar 9:133137. doi: 10.1016/j.ijcard.2025.133137.
    >> Share

  90. STRACQUALURSI M, Nemola G, Santangelo G, Moscardelli S, et al
    Monitoring SGLT2 inhibition effectiveness on pulmonary systolic pressure in heart failure with reduced ejection fraction.
    Int J Cardiol. 2025;428:133136.
    >> Share

  91. GAO S, Li D, Qiao B, Gong Y, et al
    Association of elevated levels of soluble transferrin receptor with left ventricular remodeling and mortality in patients with heart failure: Evidence from observational and genetic investigations.
    Int J Cardiol. 2025 Mar 6:133133. doi: 10.1016/j.ijcard.2025.133133.
    >> Share

  92. VICENT L, Garcia-Cosio M, Amigo JS, Guerra JM, et al
    Sex and clinical outcomes in new-onset heart failure.
    Int J Cardiol. 2025 Mar 2:133092. doi: 10.1016/j.ijcard.2025.133092.
    >> Share

  93. ABUDUKEREMU A, Chen Q, Pan Z, Liu X, et al
    Different association of HDL-C, apoA-I, and HDL-C/apoA-I with multiple outcomes in HFrEF patients.
    Int J Cardiol. 2025;422:132929.
    >> Share

    February 2025
  94. REDDY YNV, Lee JK
    Lower than expected heart rate and exercise intolerance in heart failure - Correlation or causation?
    Int J Cardiol. 2025;427:133095.
    >> Share

  95. VOORDES GHD, Voors AA, Damman K
    Response to "Regarding clinical profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction".
    Int J Cardiol. 2025 Feb 25:133096. doi: 10.1016/j.ijcard.2025.133096.
    >> Share

  96. BESTETTI RB, Otaviano AP, Cardinalli-Neto A, Machado MN, et al
    Clinical characteristics, predictors of mortality, and outcome in patients with heart failure with mildly reduced ejection fraction secondary to Chagas cardiomyopathy.
    Int J Cardiol. 2025;426:133088.
    >> Share

  97. CRAMER M, Borrelli M, Mathews L, Dewey M, et al
    Cardiac matrix-bound Nanovesicles provide insight into mechanisms of clinical heart disease progression to failure.
    Int J Cardiol. 2025;421:132892.
    >> Share

  98. DELL'ERA G, Palmisano P, Bertini M, Magnano M, et al
    Real-world adoption of left bundle branch area pacing: Insights from the Conduction-System pacing Italian Network Group (C-SING).
    Int J Cardiol. 2025;421:132879.
    >> Share

  99. BADAWY L, Ta Anyu A, Sadler M, Shamsi A, et al
    Long-term outcomes of hospitalised patients with de novo and acute decompensated heart failure.
    Int J Cardiol. 2025;425:133061.
    >> Share

  100. HUNG TC, Chien SC, Tsao CH, Wu YW, et al
    The association of coronary microvascular dysfunction and cardiac maladaptation with clinical outcomes in heart failure with preserved ejection fraction: A prospective dynamic SPECT study.
    Int J Cardiol. 2025;425:133064.
    >> Share

  101. DAVIS BJ, Kim M, Burton Y, Elman M, et al
    Myocardial contraction fraction predicts outcomes in patients enrolled in the TOPCAT trial.
    Int J Cardiol. 2025 Feb 4:133038. doi: 10.1016/j.ijcard.2025.133038.
    >> Share

    January 2025
  102. TIAN J, Dong M, Zhang X, Lu H, et al
    Reply to letter regarding "Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study".
    Int J Cardiol. 2025;423:133011.
    >> Share

  103. HIPOLITO-REIS H, Guimaraes C, Elias C, Gouveia R, et al
    A new simple chronic heart failure prognostic index based on five general parameters.
    Int J Cardiol. 2025 Jan 24:133002. doi: 10.1016/j.ijcard.2025.133002.
    >> Share

  104. KAGAMI K, Obokata M
    Prognostic value of cardiac output in different stages of heart failure.
    Int J Cardiol. 2025 Jan 22:133001. doi: 10.1016/j.ijcard.2025.133001.
    >> Share

  105. SUGIMOTO T
    The Canary in the Coal Mine: Left atrial function in heart failure.
    Int J Cardiol. 2025;423:132989.
    >> Share

  106. CHEN Y, Yang XH, Cheng YL, Zhou Q, et al
    Regarding clinical profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction.
    Int J Cardiol. 2025 Jan 17:132992. doi: 10.1016/j.ijcard.2025.132992.
    >> Share

  107. TAKEUCHI S, Kohno T, Goda A, Kohsaka S, et al
    Reply to "Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction".
    Int J Cardiol. 2025;422:132982.
    >> Share

  108. CHEN Z, Cheang I, Zhu X, Shi J, et al
    Validation of a non-invasive filling pressure (NIFP) device for measuring cardiac pressure and assessing congestion levels in patients with heart failure.
    Int J Cardiol. 2025 Jan 7:132973. doi: 10.1016/j.ijcard.2025.132973.
    >> Share

  109. KAGAMI K, Kagiyama N, Kaneko T, Harada T, et al
    Heart failure with preserved ejection fraction in atrial functional mitral regurgitation - Insight from the REVEAL-AFMR.
    Int J Cardiol. 2025;422:132958.
    >> Share

  110. AHMAD R, Khan S, Khan A, Naveed F, et al
    Critical insights on "Short-term outcomes in patients with heart failure".
    Int J Cardiol. 2025;422:132948.
    >> Share

  111. HARADA M, Motoike Y, Nomura Y, Nishimura A, et al
    Impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes.
    Int J Cardiol. 2025 Jan 2:132954. doi: 10.1016/j.ijcard.2024.132954.
    >> Share

  112. CHIMURA M, Ohtani T, Sera F, Nakamoto K, et al
    Ratio of pulmonary artery diameter to ascending aortic diameter and its association with right ventricular failure after left ventricular assist device implantation.
    Int J Cardiol. 2025;418:132596.
    >> Share

    December 2024
  113. FERRARI CHEN YF, Aimo A, Emdin M
    Heart failure with improved ejection fraction: A dynamic journey of recovery and possible relapse.
    Int J Cardiol. 2024;422:132944.
    >> Share

  114. GHAURI HF
    Letter to the editor: Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study.
    Int J Cardiol. 2024;422:132937.
    >> Share

  115. RICKEN KWLM, Lenselink C, Venema CS, van der Horst ICC, et al
    Left atrial strain predicts long-term heart failure outcomes after ST-elevation myocardial infarction.
    Int J Cardiol. 2024 Dec 22:132931. doi: 10.1016/j.ijcard.2024.132931.
    >> Share

  116. BOGH-SORENSEN S, Dons M, Shabib A, Olsen FJ, et al
    Cardiac power and the association with heart failure and cardiovascular death in the general population.
    Int J Cardiol. 2024 Dec 21:132926. doi: 10.1016/j.ijcard.2024.132926.
    >> Share

  117. PUTHENPURA MM, Wilcox J, Keane R, Demirjian S, et al
    Diuretic management protocol to improve quality and safety in managing acute heart failure in an integrated health system: An implementation science approach.
    Int J Cardiol. 2024 Dec 19:132920. doi: 10.1016/j.ijcard.2024.132920.
    >> Share

  118. MANJUNATH A, Maning J, Wu T, Bryner B, et al
    Cardiac transplantation with increased-risk donors: Trends and clinical outcomes.
    Int J Cardiol. 2024;421:132887.
    >> Share

  119. MINNECI C, Zucchini M, Gonzini L, Marini M, et al
    Serum uric acid, renal function and prognosis in patients with chronic heart failure and reduced ejection fraction. Insights from the Italian Network on Heart Failure.
    Int J Cardiol. 2024;421:132906.
    >> Share

  120. REINHARDT M, Behnes M, Weidner K, Ayasse N, et al
    Potassium levels and short-term outcomes in heart failure with mildly reduced ejection fraction.
    Int J Cardiol. 2024 Dec 2:132878. doi: 10.1016/j.ijcard.2024.132878.
    >> Share

    November 2024
  121. SHIMODE Y, Kitai T, Iwata K, Murai R, et al
    Impact of stress coping style on self-care behaviors and prognosis in patients with heart failure: A prospective longitudinal observational study.
    Int J Cardiol. 2024;421:132865.
    >> Share

  122. HUANG L, Zhou P, Zhai M, Feng J, et al
    Incidence, progression, and outcomes of heart failure with improved ejection fraction: The added value of longitudinally assessed ejection fraction.
    Int J Cardiol. 2024 Nov 26:132759. doi: 10.1016/j.ijcard.2024.132759.
    >> Share

  123. KAUR P, Ha J, Raye N, Ouwerkerk W, et al
    A systematic review of multimorbidity clusters in heart failure: Effects of methodologies.
    Int J Cardiol. 2024;420:132748.
    >> Share

  124. YANG X, Tao N, Wang T, Zhang Z, et al
    The relationship between composite inflammatory indicators and short-term outcomes in patients with heart failure.
    Int J Cardiol. 2024;420:132755.
    >> Share

  125. CHRISTINA A, Andrej B, Sener YZ
    GLP-1 RAs in the heart failure field: Kill many birds with one stone.
    Int J Cardiol. 2024;420:132739.
    >> Share

  126. NATALE F, Fusco C, Stigliani R, Golino P, et al
    Renal arterial resistance index before and after vericiguat administration: Should it be considered the fantastic five?
    Int J Cardiol. 2024;415:132467.
    >> Share

  127. KAWAJI T, Hamatani Y, Kato M, Yokomatsu T, et al
    Bundle branch block patterns during atrial fibrillation rhythm for heart failure events.
    Int J Cardiol. 2024 Nov 9:132710. doi: 10.1016/j.ijcard.2024.132710.
    >> Share

  128. AL'AREF SJ, Gautam N, Mansour M, Alqaisi O, et al
    Clinical parameters of death and heart failure hospitalization in biventricular systolic dysfunction assessed via cardiac magnetic resonance.
    Int J Cardiol. 2024;419:132709.
    >> Share

  129. MARENZI G, Cosentino N, Imparato L, Trombara F, et al
    Temporal trends (2003-2018) of in-hospital and 30-day mortality in patients hospitalized with acute heart failure.
    Int J Cardiol. 2024 Nov 2:132693. doi: 10.1016/j.ijcard.2024.132693.
    >> Share

  130. BRIGHT C, Rizvi A, Ezekwueme F, Schiff M, et al
    Impact of guideline directed medical therapy on myocardial function in adults with congenital heart disease.
    Int J Cardiol. 2024;414:132413.
    >> Share

  131. BRATSETH V, Nendl A, Raju SC, Holm K, et al
    Gut dysbiosis and neutrophil extracellular traps in chronic heart failure.
    Int J Cardiol. 2024 Nov 1:132689. doi: 10.1016/j.ijcard.2024.132689.
    >> Share

    October 2024
  132. SONG Y, Liu X
    Letter To Editor: Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction.
    Int J Cardiol. 2024 Oct 28:132688. doi: 10.1016/j.ijcard.2024.132688.
    >> Share

  133. ROWE SJ, Xiang R, Paratz ED, Takeuchi F, et al
    Left ventricular size and heart failure: A cardiac MRI assessment of 38,129 individuals from the UK Biobank.
    Int J Cardiol. 2024 Oct 26:132687. doi: 10.1016/j.ijcard.2024.132687.
    >> Share

  134. CRUCIAT RC, Gazi G, Ismaiel A, Leucuta DC, et al
    Unlocking the potential of biomarkers: The promise of adrenomedullin and its precursors in diagnosing and assessing heart failure.
    Int J Cardiol. 2024 Oct 17:132659. doi: 10.1016/j.ijcard.2024.132659.
    >> Share

  135. LANDER MM, Raina A
    Power is nothing without control: Optimizing left ventricular unloading with an automated Impella feedback control system.
    Int J Cardiol. 2024;413:132363.
    >> Share

  136. SIMONSEN JO, Modin D, Skaarup K, Djernaes K, et al
    Utilizing echocardiography and unsupervised machine learning for heart failure risk identification.
    Int J Cardiol. 2024;418:132636.
    >> Share

  137. HORIUCHI Y, Wettersten N, Asami M, Yahagi K, et al
    Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure.
    Int J Cardiol. 2024 Oct 9:132611. doi: 10.1016/j.ijcard.2024.132611.
    >> Share

  138. ALHURAYRI F, Jaynes HA, Overholser BR, Sowinski KM, et al
    Drug-induced increase in dispersion of ventricular repolarization in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2024 Oct 9:132631. doi: 10.1016/j.ijcard.2024.132631.
    >> Share

  139. HARO A, Jacob J, Rossello X, Llorens P, et al
    Impact of chronic renin-angiotensin-aldosterone inhibitors on short-term outcomes in patients with acute heart failure presenting to the emergency department. A propensity-matched analysis EAHFE cohort.
    Int J Cardiol. 2024 Oct 9:132615. doi: 10.1016/j.ijcard.2024.132615.
    >> Share

  140. BERTELLI M, Ziacchi M, van Slochteren F, Rondanina E, et al
    LV cathode position in CRT recipients: How can we benefit from CMR?
    Int J Cardiol. 2024;412:132321.
    >> Share

  141. SCRUTINIO D, Guida P, Carbonara R, Passantino A, et al
    Cardiac rehabilitation for old-old patients with heart failure and severe functional impairment.
    Int J Cardiol. 2024 Oct 1:132605. doi: 10.1016/j.ijcard.2024.132605.
    >> Share

    September 2024
  142. KUIPERS S, Kappelle LJ, Greving JP, Amier RP, et al
    Sex differences in cognitive functioning in patients with heart failure.
    Int J Cardiol. 2024 Sep 27:132603. doi: 10.1016/j.ijcard.2024.132603.
    >> Share

  143. TRIMARCHI G, Pizzino F
    An in-depth look at electrolytes in acute heart failure: The role of sodium-to-chloride ratio.
    Int J Cardiol. 2024;417:132585.
    >> Share

  144. VOORDES GHD, Voors AA, Hoegl A, Madsen CT, et al
    Clinical and proteomic profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction.
    Int J Cardiol. 2024 Sep 19:132580. doi: 10.1016/j.ijcard.2024.132580.
    >> Share

  145. FERNANDO MB, Ferreira I, Lourenco P
    Admission and discharge sodium: Chloride ratio in acute heart failure - The importance of electrolytes.
    Int J Cardiol. 2024 Sep 7:132528. doi: 10.1016/j.ijcard.2024.132528.
    >> Share

  146. TIAN J, Dong M, Sun X, Jia X, et al
    Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study.
    Int J Cardiol. 2024;417:132524.
    >> Share

  147. BARLETTA V
    Promises and challenges in advanced heart failure management through CIED-based remote monitoring.
    Int J Cardiol. 2024;417:132512.
    >> Share

  148. HUA L
    Reply to "Assessing the clinical utility of the HFpEF nomogram: A call for broader validation".
    Int J Cardiol. 2024;410:132214.
    >> Share

    August 2024
  149. NISHIKAWA T, Ueyama J, Shimizu S, Shibata Y, et al
    Redox state of human serum albumin as a post-discharge prognostic marker in patients hospitalized for heart failure.
    Int J Cardiol. 2024 Aug 28:132497. doi: 10.1016/j.ijcard.2024.132497.
    >> Share

  150. ZHANG L, Liu Z, Zeng J, Wu M, et al
    Reply to "The association between PM2.5 and heart failure".
    Int J Cardiol. 2024 Aug 28:132503. doi: 10.1016/j.ijcard.2024.132503.
    >> Share

  151. YAN T, Ming Y, Wang C
    The association between PM2.5 and heart failure.
    Int J Cardiol. 2024 Aug 27:132491. doi: 10.1016/j.ijcard.2024.132491.
    >> Share

  152. KOBAYASHI M, Yamashina A, Satomi K, Tezuka A, et al
    Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure.
    Int J Cardiol. 2024;415:132477.
    >> Share

  153. MUSEEDI AS, Samson R, Le Jemtel TH
    Menopause, epicardial adiposity and preserved ejection fraction heart failure.
    Int J Cardiol. 2024;415:132478.
    >> Share

  154. PELLEGRINO M, Villaschi A, Gasparini G, Maccallini M, et al
    Diuretic resistance in acute heart failure: Proposal for a new urinary sodium-based definition.
    Int J Cardiol. 2024 Aug 14:132456. doi: 10.1016/j.ijcard.2024.132456.
    >> Share

  155. KOYA T, Nagai T, Tada A, Nakao M, et al
    Differential impacts of self-care behavior on clinical outcomes in patients with and without recent heart failure hospitalization.
    Int J Cardiol. 2024;415:132452.
    >> Share

  156. HASHIMOTO T, Yoshitake T, Suenaga T, Yamamoto S, et al
    Effectiveness of Vericiguat on right ventricle to pulmonary artery uncoupling associated with heart failure with reduced ejection fraction.
    Int J Cardiol. 2024;415:132441.
    >> Share

  157. VAN DER LANDE ACMH, Feijen M, Egorova AD, Beles M, et al
    CIED-based remote monitoring in heart failure using the HeartLogic algorithm: Which patients benefit most?
    Int J Cardiol. 2024 Aug 3:132421. doi: 10.1016/j.ijcard.2024.132421.
    >> Share

  158. ANSARI RAMANDI MM, Hendriks PM, Voors AA, van den Bosch AE, et al
    Bioactive adrenomedullin as a marker of congestion and disease progression in patients with a systemic right ventricle.
    Int J Cardiol. 2024;408:132107.
    >> Share

    July 2024
  159. PALAGINI L, Gentile F, Emdin M
    Anxiety, depression and chronic heart failure: Bad companions getting worse over time.
    Int J Cardiol. 2024 Jul 31:132409. doi: 10.1016/j.ijcard.2024.132409.
    >> Share

  160. TSENG CH
    Metformin-associated lactic acidosis and mortality in type 2 diabetes patients hospitalized with heart failure and/or acute coronary syndrome: A neglected clinical scenario and the potential role of insulin.
    Int J Cardiol. 2024 Jul 30:132400. doi: 10.1016/j.ijcard.2024.132400.
    >> Share

  161. ABEL N, Schupp T, Schmitt A, Reinhardt M, et al
    Left ventricular diastolic dysfunction in patients with heart failure with mildly reduced ejection fraction.
    Int J Cardiol. 2024 Jul 28:132386. doi: 10.1016/j.ijcard.2024.132386.
    >> Share

  162. HAO G, Chen X, Fang Z, He Y, et al
    Association between prescription opioid use and heart failure: Cohort studies and Mendelian randomization analysis.
    Int J Cardiol. 2024 Jul 27:132404. doi: 10.1016/j.ijcard.2024.132404.
    >> Share

  163. KELLY B, Thorup L, Telinius N, Mohanakumar S, et al
    Lymphatic morphology and function in chronic right heart failure due to secondary tricuspid valve regurgitation.
    Int J Cardiol. 2024;413:132399.
    >> Share

  164. D'ERRIGO P, De Luca L, Rosato S, Giordani B, et al
    Prognostic role of coronary angiography and revascularization in patients firstly admitted for heart failure in Italy.
    Int J Cardiol. 2024 Jul 23:132369. doi: 10.1016/j.ijcard.2024.132369.
    >> Share

  165. ANDREA B, Anna D, Daniele B, Angelica C, et al
    H(2)FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation.
    Int J Cardiol. 2024 Jul 18:132385. doi: 10.1016/j.ijcard.2024.132385.
    >> Share

  166. FU K, Yang Z, Wang N, Dong Y, et al
    Recurrence of left ventricular systolic dysfunction and its risk factors in heart failure with improved ejection fraction patients receiving guideline-directed medical therapy: A trajectory analysis based on echocardiography.
    Int J Cardiol. 2024 Jul 17:132370. doi: 10.1016/j.ijcard.2024.132370.
    >> Share

  167. HUANG H, Fu B, Long T, Yu Y, et al
    Implication of geriatric nutritional risk index on treatment response and long-term prognosis in patients with cardiac resynchronization therapy.
    Int J Cardiol. 2024;407:132064.
    >> Share

  168. PINTALHAO M, Vasques-Novoa F, Barros AS, Lourenco P, et al
    Prognostic association of circulating relaxin-2 in acute heart failure.
    Int J Cardiol. 2024 Jul 11:132358. doi: 10.1016/j.ijcard.2024.132358.
    >> Share

  169. BLASCO-TURRION S, Crespo-Leiro MG, Trenado VD, Hion PLC, et al
    Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: A nationwide study.
    Int J Cardiol. 2024 Jul 9:132340. doi: 10.1016/j.ijcard.2024.132340.
    >> Share

  170. ZHANG L, Liu Z, Zeng J, Wu M, et al
    Long-term effects of air quality on hospital readmission for heart failure in patients with acute myocardial infarction.
    Int J Cardiol. 2024 Jul 6:132344. doi: 10.1016/j.ijcard.2024.132344.
    >> Share

  171. DE PONTI C, Bonaventura A
    Bioelectrical impedance analysis for early recognition of fluid congestion in heart failure: Is it the best tool?
    Int J Cardiol. 2024 Jul 5:132314. doi: 10.1016/j.ijcard.2024.132314.
    >> Share

  172. MEGURO T
    Diversity in heart failure management: Quo Vadis guideline-directed medical therapy?
    Int J Cardiol. 2024 Jul 5:132325. doi: 10.1016/j.ijcard.2024.132325.
    >> Share

  173. DE ALMEIDA PINHO I, Pimentel MJ, Oliveira C, Matos MI, et al
    Office- versus home-based evaluation of quality of life in heart failure with reduced ejection fraction: A randomized study.
    Int J Cardiol. 2024 Jul 4:132341. doi: 10.1016/j.ijcard.2024.132341.
    >> Share

  174. TERSALVI G, Bossard M, Aeschbacher S, Wiencierz A, et al
    Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.
    Int J Cardiol. 2024 Jul 2:132320. doi: 10.1016/j.ijcard.2024.132320.
    >> Share

  175. ALBULUSHI A
    Assessing the clinical utility of the HFpEF nomogram: A call for broader validation.
    Int J Cardiol. 2024;406:132038.
    >> Share

  176. NOGIMORI Y, Sato K, Takamizawa K, Ogawa Y, et al
    Prediction of adverse cardiovascular events in children using artificial intelligence-based electrocardiogram.
    Int J Cardiol. 2024;406:132019.
    >> Share

    June 2024
  177. ESPERSEN C, Campbell RT, Claggett BL, Biering-Sorensen T, et al
    Reply to: Instrumental outcome modifiers to be considered among patients with acute heart failure.
    Int J Cardiol. 2024 Jun 29:132310. doi: 10.1016/j.ijcard.2024.132310.
    >> Share

  178. TIMOTEO AT, Barbas Albuquerque F, Lacerda Teixeira B
    Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target.
    Int J Cardiol. 2024;412:132303.
    >> Share

  179. ABDIN A, Bohm M, Shahim B, Karlstrom P, et al
    Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies.
    Int J Cardiol. 2024 Jun 27:132304. doi: 10.1016/j.ijcard.2024.132304.
    >> Share

  180. AIMO A, Arzilli C, Castiglione V, Morfino P, et al
    Safety and efficacy of levosimendan in patients with cardiac amyloidosis.
    Int J Cardiol. 2024;405:131963.
    >> Share

  181. FORTUNI F, Tavazzi L, Ciliberti G
    Digital health in heart failure: Empowering physicians to enhance patient care.
    Int J Cardiol. 2024 Jun 15:132261. doi: 10.1016/j.ijcard.2024.132261.
    >> Share

  182. FERREIRA JP, Zannad F, Solomon SD
    Reply to the letter entitled "Inflammation in Heart Failure with Preserved Ejection Fraction: A Bystander or A Participant?" by Zhong M and Yan X.
    Int J Cardiol. 2024 Jun 14:132278. doi: 10.1016/j.ijcard.2024.132278.
    >> Share

  183. KAMAR SA, Oostdijk B, Andrzejczyk K, Constantinescu A, et al
    Temporal evolution of anxiety and depression in chronic heart failure and its association with clinical outcome.
    Int J Cardiol. 2024 Jun 14:132274. doi: 10.1016/j.ijcard.2024.132274.
    >> Share

  184. DAUNGSUPAWONG H, Wiwanitkit V
    Comment on "Accuracy and consistency of online large language model-based artificial intelligence chat platforms in answering patients' questions about heart failure: Doi: 10.1016/j.ijcard.2024.132115".
    Int J Cardiol. 2024;410:132242.
    >> Share

  185. KRITTAYAPHONG R, Yingchoncharoen T, Puwanant S, Boonyapiphat T, et al
    Reassessing heart failure therapy in Thailand: Patient insights and treatment outcomes from the Thai heart failure registry.
    Int J Cardiol. 2024 Jun 4:132235. doi: 10.1016/j.ijcard.2024.132235.
    >> Share

  186. CAI Q, Li Q, Zhong S, Chen M, et al
    Ultrasound-targeted microbubble destruction rapidly improves left ventricular function in rats with ischemic cardiac dysfunction.
    Int J Cardiol. 2024;404:131943.
    >> Share

  187. NABESHIMA Y, Tanaka A, Node K
    Sweet relationship between SGLT2 inhibition and heart failure.
    Int J Cardiol. 2024;410:132223.
    >> Share

    May 2024
  188. LEE S, Battumur B, Lee JE, Park SH, et al
    Assessing lung fluid status using noninvasive bioelectrical impedance analysis in patients with acute heart failure: A pilot study.
    Int J Cardiol. 2024;409:132205.
    >> Share

  189. TADA A, Nagai T, Anzai T
    Is growth differentiation factor-15 a useful biomarker for chronic heart failure across body size?
    Int J Cardiol. 2024 May 23:132204. doi: 10.1016/j.ijcard.2024.132204.
    >> Share

  190. TAKEUCHI S, Kohno T, Goda A, Shiraishi Y, et al
    Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction.
    Int J Cardiol. 2024;409:132190.
    >> Share

  191. LIU H, Xu G
    SNHG1/miR-15a-5p/Drd5: A potential mechanism for treating heart failure.
    Int J Cardiol. 2024;409:132188.
    >> Share

  192. TADAFUMI S
    Pulmonary fluid redistribution during exercise and recovery in chronic heart failure.
    Int J Cardiol. 2024 May 14:132173. doi: 10.1016/j.ijcard.2024.132173.
    >> Share

  193. KAWAI A, Nagatomo Y, Yukino-Iwashita M, Ikegami Y, et al
    Supra-normal and mildly reduced ejection fraction in women -An overlooked vulnerable subpopulation in heart failure.
    Int J Cardiol. 2024 May 12:132166. doi: 10.1016/j.ijcard.2024.132166.
    >> Share

  194. FEDERICA P, Samantha B, Davide A, Lucia C, et al
    Serum uric acid to eGFR ratio correlates with adverse outcomes in elderly hospitalized for acute heart failure.
    Int J Cardiol. 2024 May 11:132160. doi: 10.1016/j.ijcard.2024.132160.
    >> Share

  195. HUNG KC, Chao CT
    Instrumental outcome modifiers to be considered among patients with acute heart failure.
    Int J Cardiol. 2024;408:132145.
    >> Share

  196. ZHONG M, Yan X
    Inflammation in heart failure with preserved ejection fraction: A bystander or a participant?
    Int J Cardiol. 2024;408:132144.
    >> Share

  197. COLLUOGLU IT, Celik A, Ata N, Ural D, et al
    Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy.
    Int J Cardiol. 2024;407:132109.
    >> Share

  198. ALBULUSHI A, Al Kindi DI, Moawwad N, Kamel AM, et al
    Digital health technologies in enhancing patient and caregiver engagement in heart failure management: Opportunities and challenges.
    Int J Cardiol. 2024 May 2:132116. doi: 10.1016/j.ijcard.2024.132116.
    >> Share

  199. SPERLONGANO S, Benfari G, Ilardi F, Lisi M, et al
    Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy.
    Int J Cardiol. 2024;402:131885.
    >> Share

    April 2024
  200. KOZAILY E, Geagea M, Akdogan ER, Atkins J, et al
    Accuracy and consistency of online large language model-based artificial intelligence chat platforms in answering patients' questions about heart failure.
    Int J Cardiol. 2024 Apr 30:132115. doi: 10.1016/j.ijcard.2024.132115.
    >> Share

  201. TERAMOTO K, Nochioka K, Sakata Y, Kato ET, et al
    Growth differentiation factor-1?5 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum.
    Int J Cardiol. 2024 Apr 23:132093. doi: 10.1016/j.ijcard.2024.132093.
    >> Share

  202. CHEW-HARRIS J, Frampton C, Greer C, Appleby S, et al
    Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness.
    Int J Cardiol. 2024 Apr 19:132071. doi: 10.1016/j.ijcard.2024.132071.
    >> Share

  203. PEZZUTO B, Contini M, Berna G, Galotta A, et al
    Dynamic trend of lung fluid movement during exercise in heart failure: From lung imaging to alveolar-capillary membrane function.
    Int J Cardiol. 2024 Apr 19:132041. doi: 10.1016/j.ijcard.2024.132041.
    >> Share

  204. HONG Y, Gao Z, Wei H, Wei Y, et al
    Bi-directional association of body size and composition with heart failure: A Mendelian randomization study.
    Int J Cardiol. 2024 Apr 19:132069. doi: 10.1016/j.ijcard.2024.132069.
    >> Share

  205. JONG CB, Lu TS, Chen JW
    Reply to comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Apr 10:132031. doi: 10.1016/j.ijcard.2024.132031.
    >> Share

  206. ESPERSEN C, Campbell RT, Claggett BL, Lewis EF, et al
    Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure.
    Int J Cardiol. 2024 Apr 8:132036. doi: 10.1016/j.ijcard.2024.132036.
    >> Share

  207. GLINGE C, Rossetti S, Oestergaard LB, Stampe NK, et al
    Familial clustering of unexplained heart failure - A Danish nationwide cohort study.
    Int J Cardiol. 2024 Apr 5:132028. doi: 10.1016/j.ijcard.2024.132028.
    >> Share

  208. NAKAO M, Nagai T, Anzai T
    Iron supplementation is a residual piece of management in Asian patients with heart failure?
    Int J Cardiol. 2024 Apr 4:132014. doi: 10.1016/j.ijcard.2024.132014.
    >> Share

  209. DE MICHIELI L, Stoppa G, Sinigiani G, Previato L, et al
    Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy.
    Int J Cardiol. 2024;400:131804.
    >> Share

  210. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
    Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
    Int J Cardiol. 2024;400:131768.
    >> Share

  211. GARCIA-MOLL X, Lopez L
    Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results.
    Int J Cardiol. 2024;400:131706.
    >> Share

    March 2024
  212. CHENG Y, Zhang Q
    Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
    >> Share

  213. YAO L, Gong X, Liu Y, Hao K, et al
    The miR-195-3p/BDNF axis is a promising therapeutic for heart failure.
    Int J Cardiol. 2024 Mar 22:131991. doi: 10.1016/j.ijcard.2024.131991.
    >> Share

  214. CARIGI S, Gentile P, Gori M, Tinti D, et al
    Clinical characteristics, treatment, trajectories and outcome of patients with dilated cardiomyopathy in a national heart failure registry.
    Int J Cardiol. 2024 Mar 19:131986. doi: 10.1016/j.ijcard.2024.131986.
    >> Share

  215. KARAKITSOS P, Mylonas KS
    Raw data were not disclosed in 95% of PubMed-indexed heart failure meta-analyses in 2021: A systematic analysis of transparency.
    Int J Cardiol. 2024 Mar 19:131987. doi: 10.1016/j.ijcard.2024.131987.
    >> Share

  216. HUA L, Zhang R, Chen R, Shao W, et al
    A nomogram for predicting the risk of heart failure with preserved ejection fraction.
    Int J Cardiol. 2024 Mar 18:131973. doi: 10.1016/j.ijcard.2024.131973.
    >> Share

  217. LUND-ANDERSEN C, Yafasova A, Hofsten D, Thune JJ, et al
    Association between QRS shortening and mortality after cardiac resynchronization therapy: Results from the DANISH study.
    Int J Cardiol. 2024;399:131700.
    >> Share

  218. CHAO-CHEN L
    Letter to the Editor: "Changes in walking speed 6 months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure".
    Int J Cardiol. 2024 Mar 13:131958. doi: 10.1016/j.ijcard.2024.131958.
    >> Share

  219. BACKHAUS SJ, Schulz A, Lange T, Schmidt-Schweda LS, et al
    Prognostic and diagnostic implications of impaired rest and exercise-stress left atrial compliance in heart failure with preserved ejection fraction: Insights from the HFpEF stress trial.
    Int J Cardiol. 2024 Mar 11:131949. doi: 10.1016/j.ijcard.2024.131949.
    >> Share

  220. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
    Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
    Int J Cardiol. 2024;398:131601.
    >> Share

    February 2024
  221. KIKO T, Aoki T
    The relationship between duration of delirium and clinical outcomes in patients with acute heart failure.
    Int J Cardiol. 2024 Feb 23:131902. doi: 10.1016/j.ijcard.2024.131902.
    >> Share

  222. LUO Z, Gong X, Liu Y, Hao K, et al
    Mitochondrial dysfunction due to miR-210/Drd5/ROS axis is a potential mechanism of heart failure.
    Int J Cardiol. 2024 Feb 20:131897. doi: 10.1016/j.ijcard.2024.131897.
    >> Share

  223. GUAZZI M, Crisci G
    Exercise mean PAP to CO relationship: An insightful endpoint for testing therapeutic interventions in heart failure.
    Int J Cardiol. 2024 Feb 20:131899. doi: 10.1016/j.ijcard.2024.131899.
    >> Share

  224. SIM DKL, Mittal S, Zhang J, Hung CL, et al
    Expert recommendations for the management of iron deficiency in patients with heart failure in Asia.
    Int J Cardiol. 2024 Feb 19:131890. doi: 10.1016/j.ijcard.2024.131890.
    >> Share

  225. LERMAN TT, Greenberg N, Fishman B, Goldman A, et al
    The real-world safety of sacubitril / valsartan among older adults (>/=75): A pharmacovigilance study from the FDA data.
    Int J Cardiol. 2024;397:131613.
    >> Share

  226. LV L, Chen Q, Lu J, Zhao Q, et al
    Potential regulatory role of epigenetic modifications in aging-related heart failure.
    Int J Cardiol. 2024 Feb 13:131858. doi: 10.1016/j.ijcard.2024.131858.
    >> Share

  227. ISMAIL TF
    Understanding heart failure and cardiomyopathy in Africa: Insights from cardiovascular magnetic resonance.
    Int J Cardiol. 2024 Feb 12:131847. doi: 10.1016/j.ijcard.2024.131847.
    >> Share

  228. HAGE C, Lund LH
    Inflammation and myeloperoxidase - The next treatment targets in heart failure?
    Int J Cardiol. 2024 Feb 5:131834. doi: 10.1016/j.ijcard.2024.131834.
    >> Share

  229. LI G, Liu X, Long A, Feng J, et al
    An inducible mouse model of heart failure targeted to cardiac Drd5 deficiency detonating mitochondrial oxidative stress.
    Int J Cardiol. 2024;396:131560.
    >> Share

  230. IANNACCONE M, Barbero U, Franchin L, Montabone A, et al
    Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlle
    Int J Cardiol. 2024;396:131428.
    >> Share

    January 2024
  231. FERREIRA JP, Claggett BL, Liu J, Sharma A, et al
    High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT.
    Int J Cardiol. 2024 Jan 31:131818. doi: 10.1016/j.ijcard.2024.131818.
    >> Share

  232. XU L, Chen Y, Chen S, Wang G, et al
    Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study.
    Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
    >> Share

  233. MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
    Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
    Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
    >> Share

  234. YAMAGUCHI N, Hirata Y, Nishio S, Takahashi T, et al
    Pulmonary pressure-flow responses to exercise in heart failure treated with angiotensin receptor neprilysin inhibitor.
    Int J Cardiol. 2024 Jan 20:131789. doi: 10.1016/j.ijcard.2024.131789.
    >> Share

  235. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
    Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
    Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
    >> Share

  236. KANG DW, Kang SH, Lee K, Nam K, et al
    Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis.
    Int J Cardiol. 2024 Jan 17:131786. doi: 10.1016/j.ijcard.2024.131786.
    >> Share

  237. CHERBI M, Bouisset F, Bonnefoy E, Lamblin N, et al
    Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
    Int J Cardiol. 2024;395:131578.
    >> Share

  238. MUROKE V, Jalanko M, Haukka J, Anttila V, et al
    Long-term outcome after surgical correction of sinus venosus defect in a nationwide register-based cohort study.
    Int J Cardiol. 2024;395:131433.
    >> Share

  239. HANADA S, Adachi T, Iwatsu K, Kamisaka K, et al
    Changes in walking speed 6?months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure.
    Int J Cardiol. 2024 Jan 11:131778. doi: 10.1016/j.ijcard.2024.131778.
    >> Share

  240. QUATTRONE F, Aimo A, Zuccarino S, Morelli MS, et al
    Unmet needs in end-of-life care for heart failure patients.
    Int J Cardiol. 2024 Jan 10:131750. doi: 10.1016/j.ijcard.2024.131750.
    >> Share

  241. AIKAWA Y, Ogata S, Honda S, Nagai T, et al
    Prolonged delirium during hospitalization is associated with worse long-term and short-term outcomes in patients with acute heart failure.
    Int J Cardiol. 2024 Jan 10:131776. doi: 10.1016/j.ijcard.2024.131776.
    >> Share

  242. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
    Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
    Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
    >> Share

  243. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
    Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
    Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
    >> Share

  244. MIYOSHI T
    A novel genetically engineered mouse model for investigating heart failure mechanisms and therapeutic interventions.
    Int J Cardiol. 2024 Jan 3:131703. doi: 10.1016/j.ijcard.2023.131703.
    >> Share

  245. EGBE AC, Abozied O, Miranda WR, Younis A, et al
    Prognostic role of inferior vena collapsibility index in congenital heart disease: A validation study.
    Int J Cardiol. 2024;394:131399.
    >> Share

    December 2023
  246. SAEED S, Bleie O
    Prognostic validation of first-phase ejection fraction in patients with heart failure: A new piece of evidence.
    Int J Cardiol. 2023 Dec 31:131692. doi: 10.1016/j.ijcard.2023.131692.
    >> Share

  247. TAN Z, Liu Y, Hong K
    The association between serum chloride and mortality in ICU patients with heart failure: The impact of bicarbonate.
    Int J Cardiol. 2023 Dec 22:131672. doi: 10.1016/j.ijcard.2023.131672.
    >> Share

  248. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
    Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
    Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
    >> Share

  249. WONG CN, Gui XY, Rabkin SW
    Myeloperoxidase, carnitine, and derivatives of reactive oxidative metabolites in heart failure with preserved versus reduced ejection fraction: A meta-analysis.
    Int J Cardiol. 2023 Dec 13:131657. doi: 10.1016/j.ijcard.2023.131657.
    >> Share

  250. OZLEK B
    Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
    Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
    >> Share

  251. HU H, Yang J
    Heart failure complicated by atrial fibrillation: How to make better choices for anticoagulation?
    Int J Cardiol. 2023 Dec 6:131644. doi: 10.1016/j.ijcard.2023.131644.
    >> Share

  252. ELIA E, Bruno F, Crimi G, Wanha W, et al
    Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
    Int J Cardiol. 2023 Dec 5:131622. doi: 10.1016/j.ijcard.2023.131622.
    >> Share

  253. GAO Y, Liu M, Ju Z, Wang H, et al
    Entropy as a novel predictor of cardiovascular events in patients with left ventricular noncompaction.
    Int J Cardiol. 2023;392:131279.
    >> Share

    November 2023
  254. JIN C, Chen G, Zhao C, Wu Y, et al
    First-phase ejection fraction to predict adverse outcomes in patients with heart failure.
    Int J Cardiol. 2023 Nov 30:131612. doi: 10.1016/j.ijcard.2023.131612.
    >> Share

  255. CHOI HM, Hwang IC, Choi HJ, Yoon YE, et al
    Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients.
    Int J Cardiol. 2023 Nov 27:131611. doi: 10.1016/j.ijcard.2023.131611.
    >> Share

  256. MORONI F, Corna G, Del Buono MG, Golino M, et al
    Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2023 Nov 26:131610. doi: 10.1016/j.ijcard.2023.131610.
    >> Share

  257. TAYAL B, Rorth R, Kristensen SL, Wissenberg M, et al
    Comparative outcomes in patients with preexisting heart failure to those without heart failure after out-of-hospital cardiac arrest: A nationwide registry study.
    Int J Cardiol. 2023 Nov 18:131595. doi: 10.1016/j.ijcard.2023.131595.
    >> Share

  258. ALEXANDRINO FB, Faaborg-Andersen CC, da Silva-de Abreu A
    Anticoagulation in patients with atrial fibrillation and heart failure: More than meets the eye?
    Int J Cardiol. 2023 Nov 16:131591. doi: 10.1016/j.ijcard.2023.131591.
    >> Share

  259. LAU ATC, DiDomenico RJ, Kim K
    Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with Heart failure with preserved ejection fraction (HFpEF) in United States.
    Int J Cardiol. 2023 Nov 16:131598. doi: 10.1016/j.ijcard.2023.131598.
    >> Share

  260. ROSSI VA, Laptseva N, Nebunu D, Haider T, et al
    Impaired retinal micro-vascular function in patients with atrial fibrillation.
    Int J Cardiol. 2023 Nov 16:131592. doi: 10.1016/j.ijcard.2023.131592.
    >> Share

  261. D'AMARIO D, Laborante R, Bianchini E, Galli M, et al
    Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials.
    Int J Cardiol. 2023;391:131219.
    >> Share

  262. CHAVALI S, Barua S, Adji A, Robson D, et al
    Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices.
    Int J Cardiol. 2023;391:131259.
    >> Share

  263. LI ZH, Zhong WF, Qiu CS, Yang P, et al
    Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
    Int J Cardiol. 2023 Nov 5:131567. doi: 10.1016/j.ijcard.2023.131567.
    >> Share

  264. DORES H, Toste A, Cardim N
    Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
    Int J Cardiol. 2023;390:131260.
    >> Share

    October 2023
  265. MASE M, Rossi M, Setti M, Barbati G, et al
    Applicability and performance of heart failure prognostic scores in dilated cardiomyopathy: The real-world experience of an Italian referral center for cardiomyopathies.
    Int J Cardiol. 2023 Oct 29:131562. doi: 10.1016/j.ijcard.2023.131562.
    >> Share

  266. KOSEOGLU FD, Ozlek B
    Hemoglobin to red cell distribution width ratio in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Oct 27:131556. doi: 10.1016/j.ijcard.2023.131556.
    >> Share

  267. SERAFIN A, Jasic-Szpak E, Marwick TH, Przewlocka-Kosmala M, et al
    Contribution of reduced skeletal muscle perfusion reserve to exercise intolerance in heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Oct 21:131553. doi: 10.1016/j.ijcard.2023.131553.
    >> Share

  268. SERI A, Rabadi A, Baral N, Andi K, et al
    Prevalence of respiratory failure and use of mechanical ventilation in heart failure patients undergoing left atrial appendage occlusion device implantation.
    Int J Cardiol. 2023 Oct 21:131552. doi: 10.1016/j.ijcard.2023.131552.
    >> Share

  269. ZITO A, Restivo A, D'Amario D
    Reply to "Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis".
    Int J Cardiol. 2023 Oct 20:131545. doi: 10.1016/j.ijcard.2023.131545.
    >> Share

  270. ANSARI RAMANDI MM, Yarmohammadi H, Gareb B, Voors AA, et al
    Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: A systematic review and meta-analysis.
    Int J Cardiol. 2023;389:131159.
    >> Share

  271. JAIN SS, Yu J, Arnott C, Neal B, et al
    Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial.
    Int J Cardiol. 2023 Oct 14:131444. doi: 10.1016/j.ijcard.2023.131444.
    >> Share

  272. IMANISHI J, Iwasaki M, Ujiro S, Nakano T, et al
    Accuracy of lung ultrasound examinations of residual congestion performed by novice residents in patients with acute heart failure.
    Int J Cardiol. 2023 Oct 14:131446. doi: 10.1016/j.ijcard.2023.131446.
    >> Share

  273. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
    Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
    Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
    >> Share

  274. MOCKEL M, Pudasaini S, Baberg HT, Levenson B, et al
    Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study.
    Int J Cardiol. 2023 Oct 10:131434. doi: 10.1016/j.ijcard.2023.131434.
    >> Share

  275. ROONGSANGMANOON W, Wongsoasup A, Chichareon P, Suwannasom P, et al
    Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Int J Cardiol. 2023;388:131167.
    >> Share

    September 2023
  276. ZHENG H, Yin Z, Luo X, Zhou Y, et al
    Associations between systemic immunity-inflammation index and heart failure: Evidence from the NHANES 1999-2018.
    Int J Cardiol. 2023 Sep 26:131400. doi: 10.1016/j.ijcard.2023.131400.
    >> Share

  277. FONDERICO C, Pergola V, Faccenda D, Salucci A, et al
    Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients.
    Int J Cardiol. 2023 Sep 23:131391. doi: 10.1016/j.ijcard.2023.131391.
    >> Share

  278. BAUMHOVE L, Bomer N, Tromp J, van Essen BJ, et al
    Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D.
    Int J Cardiol. 2023 Sep 21:131384. doi: 10.1016/j.ijcard.2023.131384.
    >> Share

  279. CHEN H, Zhen Z, Dong Y, Liu C, et al
    Hemoglobin to red cell distribution width ratio: A predictor of clinical outcome and diuretic response in patients with acute heart failure.
    Int J Cardiol. 2023 Sep 20:131368. doi: 10.1016/j.ijcard.2023.131368.
    >> Share

  280. LI T, Li Z, Guo S, Jiang S, et al
    The value of using left ventricular pressure-strain loops to evaluate myocardial work in predicting heart failure with improved ejection fraction.
    Int J Cardiol. 2023 Sep 19:131366. doi: 10.1016/j.ijcard.2023.131366.
    >> Share

  281. ANDI K, Abozied O, Miranda WR, Anderson JH, et al
    Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease.
    Int J Cardiol. 2023;387:131152.
    >> Share

  282. TSABEDZE N, Mpanya D, Bailly C, Nel S, et al
    Clinical characteristics and one-year all-cause mortality outcomes in Africans with dilated cardiomyopathy.
    Int J Cardiol. 2023;387:131142.
    >> Share

  283. LEE YH, Kim SM, Kim EK, Park SJ, et al
    Pattern of pericardial calcification determines mid-term postoperative outcomes after pericardiectomy in chronic constrictive pericarditis.
    Int J Cardiol. 2023;387:131133.
    >> Share

  284. ZHANG TY, An DA, Zhou H, Ni Z, et al
    Fractal analysis: Left ventricular trabecular complexity cardiac MRI adds independent risks for heart failure with preserved ejection fraction in participants with end-stage renal disease.
    Int J Cardiol. 2023 Sep 9:131334. doi: 10.1016/j.ijcard.2023.131334.
    >> Share

  285. LEE K, Jung JH, Kwon W, Ohn C, et al
    The prognostic value of cardiopulmonary exercise testing and HFA-PEFF in patients with unexplained dyspnea and preserved left ventricular ejection fraction.
    Int J Cardiol. 2023;386:74-82.
    >> Share

    August 2023
  286. KHAZAEI S, Jenabi E
    Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
    Int J Cardiol. 2023 Aug 22:131281. doi: 10.1016/j.ijcard.2023.131281.
    >> Share

  287. PUST F, Deis T, Larsson J, Hansen BL, et al
    Importance of heart failure duration for development of pulmonary hypertension in advanced heart failure.
    Int J Cardiol. 2023 Aug 19:131232. doi: 10.1016/j.ijcard.2023.131232.
    >> Share

  288. CHO Y, Ueda T, Kotani S, Okada K, et al
    AATS 2023: Left ventricular restoration with scar exclusion in the surgical treatment for ischemic heart failure.
    Int J Cardiol. 2023 Aug 18:131277. doi: 10.1016/j.ijcard.2023.131277.
    >> Share

  289. DOGAR ME, Azeem B, Asim R
    Comment on SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
    Int J Cardiol. 2023 Aug 9:131255. doi: 10.1016/j.ijcard.2023.131255.
    >> Share

  290. LO JJ, Tromp J, Ouwerkwerk W, Ong MEH, et al
    Examining predictors for 6-month mortality and healthcare utilization for patients admitted for heart failure in the acute care setting.
    Int J Cardiol. 2023 Aug 1:131237. doi: 10.1016/j.ijcard.2023.131237.
    >> Share

    July 2023
  291. SANCHIS L, Farrero M
    Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
    Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
    >> Share

  292. DE CLERCQ L, Er A, Handoko ML, van Weert HCPM, et al
    Characteristics of heart failure in the Amsterdam metropolitan area (AMSTERDAM-HF): Data from a dynamic general practice cohort (2011-2021).
    Int J Cardiol. 2023 Jul 25:131217. doi: 10.1016/j.ijcard.2023.131217.
    >> Share

  293. TAVERAS HIRALDO A, Canahuate Rodriguez G
    Predicting heart failure rollback.
    Int J Cardiol. 2023 Jul 20:131197. doi: 10.1016/j.ijcard.2023.131197.
    >> Share

  294. JONG CB, Lu TS, Chen TY, Chen CK, et al
    Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome.
    Int J Cardiol. 2023 Jul 18:131195. doi: 10.1016/j.ijcard.2023.131195.
    >> Share

  295. PAVLOV M, Vidak M
    Safety of benzodiazepines in patients with acute heart failure: Questions to be answered.
    Int J Cardiol. 2023 Jul 14:131191. doi: 10.1016/j.ijcard.2023.131191.
    >> Share

  296. ICHIHARA YK, Shiraishi Y, Kohsaka S, Nakano S, et al
    Association of pre-hospital precipitating factors with short- and long-term outcomes of acute heart failure patients: A report from the WET-HF2 registry.
    Int J Cardiol. 2023 Jul 10:131161. doi: 10.1016/j.ijcard.2023.131161.
    >> Share

  297. ZITO A, Restivo A, Ciliberti G, Laborante R, et al
    Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
    Int J Cardiol. 2023 Jul 8:131163. doi: 10.1016/j.ijcard.2023.131163.
    >> Share

  298. SUN Y, Wang C, Ren J
    CRT upgrading might be a potential therapy in pacemaker-induced cardiomyopathy.
    Int J Cardiol. 2023;382:62.
    >> Share

  299. WANG RJ, Xu C, Tang HF
    A cardiovascular polypharmacy perspective on octogenarians with HFpEF.
    Int J Cardiol. 2023;382:60-61.
    >> Share

    June 2023
  300. CASTIGLIONE V, Gentile F, Vergaro G
    Cachexia, sarcopenia and heart failure: A last mile to be walked.
    Int J Cardiol. 2023 Jun 24:131131. doi: 10.1016/j.ijcard.2023.131131.
    >> Share

  301. MORITA K, Miyamoto Y, Mizuno A, Shirane S, et al
    Impact of a financial incentive scheme for team-based palliative care in patients with heart failure in Japan: A nationwide database study.
    Int J Cardiol. 2023 Jun 24:131145. doi: 10.1016/j.ijcard.2023.131145.
    >> Share

  302. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
    The long-term clinical course of moderate tricuspid regurgitation.
    Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
    >> Share

  303. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
    2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
    Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
    >> Share

  304. GALATI G, Germanova O, Pedretti RFE, Ambrosio G, et al
    Hypotension and optimization of heart failure therapy after a recent hospitalization for heart failure: When the going gets tough, the tough get going.
    Int J Cardiol. 2023 Jun 13:131118. doi: 10.1016/j.ijcard.2023.131118.
    >> Share

  305. CAMILLI M, Iannaccone G, Russo M, Meucci MC, et al
    Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study.
    Int J Cardiol. 2023 Jun 6:S0167-5273(23)00835.
    >> Share

    May 2023
  306. ZHANG X, Lv X, Wang N, Yu S, et al
    WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2023 May 29:S0167-5273(23)00738.
    >> Share

  307. MUTOLI M, Martelli F, Spinetti G
    TfR1 gene expression as a potential biomarker for iron deficiency in heart failure.
    Int J Cardiol. 2023 May 23:S0167-5273(23)00722.
    >> Share

  308. WU L, Wu M, Zhang X, Chen S, et al
    Increased arterial stiffness elevates the risk of heart failure in diabetic patients.
    Int J Cardiol. 2023 May 23:S0167-5273(23)00732.
    >> Share

  309. ANGELICO-GONCALVES A, Leite AR, Neves JS, Saraiva F, et al
    Changes in health-related quality of life and treatment effects in chronic heart failure: A meta-analysis.
    Int J Cardiol. 2023 May 19:S0167-5273(23)00726.
    >> Share

  310. MEIJS C, Brugts JJ, Lund LH, Linssen GCM, et al
    Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction.
    Int J Cardiol. 2023 May 16:S0167-5273(23)00718.
    >> Share

  311. CABRERA C, Frisk C, Lofstrom U, Lynga P, et al
    Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle.
    Int J Cardiol. 2023;379:82-88.
    >> Share

  312. KUCHTARUK AA, Sparrow RT, Azzalini L, Garcia S, et al
    Unplanned readmissions after Impella mechanical circulatory support.
    Int J Cardiol. 2023;379:48-59.
    >> Share

  313. ALHAKAK AS, Olsen FJ, Skaarup KG, Lassen MCH, et al
    Changes in cardiac time intervals over a decade and the risk of incident heart failure: The Copenhagen City heart study.
    Int J Cardiol. 2023 May 11:S0167-5273(23)00709.
    >> Share

  314. MELENDO-VIU M, Dobarro D, Lopez AM, Dominguez LM, et al
    Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?
    Int J Cardiol. 2023 May 9:S0167-5273(23)00658.
    >> Share

  315. MAGRI D, Palermo P, Salvioni E, Mapelli M, et al
    Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2023 May 8:S0167-5273(23)00659.
    >> Share

  316. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
    Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
    >> Share

  317. KOH SJQ, Yap J, Jiang Y, Sng GGR, et al
    Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study.
    Int J Cardiol. 2023;378:105-110.
    >> Share

    April 2023
  318. ASAUMI Y
    Peripheral vein pressure as a less-invasive marker at the vulnerable phase after hospitalization of heart failure.
    Int J Cardiol. 2023 Apr 28:S0167-5273(23)00593.
    >> Share

  319. BOTTIROLI M, Calini A, Morici N, Tavazzi G, et al
    Acute kidney injury in patients with acute decompensated heart failure-cardiogenic shock: Prevalence, risk factors and outcome.
    Int J Cardiol. 2023 Apr 28:S0167-5273(23)00612.
    >> Share

  320. ZEITOUNI M, Morlon Q, Silvain J, Procopi N, et al
    Implication of the new definition of pulmonary hypertension in patients evaluated for heart transplantation.
    Int J Cardiol. 2023 Apr 27:S0167-5273(23)00602.
    >> Share

  321. SINGAM NSV, Tabi M, Wiley B, Anavekar N, et al
    Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
    Int J Cardiol. 2023 Apr 26:S0167-5273(23)00595.
    >> Share

  322. NISHINO M, Egami Y, Yamada T, Yasumura Y, et al
    Reply to "Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction".
    Int J Cardiol. 2023 Apr 17:S0167-5273(23)00536.
    >> Share

  323. FERREIRA JP, Cleland JG, Girerd N, Rossignol P, et al
    Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
    Int J Cardiol. 2023;377:86-88.
    >> Share

  324. CHRISTOPH M, Marius S, Karl S, Friedrich K, et al
    Efficacy of CRT upgrade in pacemaker-induced cardiomyopathy in an outpatient clinic - Results of a prospective registry.
    Int J Cardiol. 2023;377:60-65.
    >> Share

  325. YANG Q, Wu H, Liu D, Li Y, et al
    Discussion of a study on the role of EMS in prognosis of elderly patients with AHF.
    Int J Cardiol. 2023;377:91.
    >> Share

  326. SALAMANCA-BAUTISTA P, Romero-Correa M, Formiga F, Antequera-Martin-Portugues I, et al
    Safety of benzodiazepines in patients with acute heart failure: A propensity score-matching study.
    Int J Cardiol. 2023 Apr 14:S0167-5273(23)00529.
    >> Share

  327. EDER M, Griffin M, Moreno-Villagomez J, Bellumkonda L, et al
    The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial.
    Int J Cardiol. 2023 Apr 4:S0167-5273(23)00517.
    >> Share

    March 2023
  328. LUO Q, Zhuang B, Li G, Jiang Y, et al
    Consistency evaluation of exercise target heart rate determined by resting heart rate and anaerobic threshold in chronic heart failure patients.
    Int J Cardiol. 2023 Mar 29:S0167-5273(23)00467.
    >> Share

  329. HORTEGAL RA, Valeri R, Grizante M, Cancellier R, et al
    Afterload increase challenge unmasks systolic abnormalities in heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Mar 21:S0167-5273(23)00453.
    >> Share

  330. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
    Prevalence and prognostic impact of the coexistence of cachexia and sarcopenia in older patients with heart failure.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00447.
    >> Share

  331. TAKIMURA H, Taniguchi R, Tsuzuki I, Tajima E, et al
    Impact of the time-to-target rate of urine volume concept on the outcome of acute decompensated heart failure.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00445.
    >> Share

  332. KUMAR HU, Nearing BD, Mittal S, Premchand RK, et al
    Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00440.
    >> Share

  333. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
    Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Mar 11:S0167-5273(23)00396.
    >> Share

  334. BURGER PM, Koudstaal S, Dorresteijn JAN, Savarese G, et al
    Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
    Int J Cardiol. 2023 Mar 11:S0167-5273(23)00395.
    >> Share

  335. HEEGAARD B, Deis T, Rossing K, Ersboll M, et al
    Diabetes mellitus and hemodynamics in advanced heart failure.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00341.
    >> Share

  336. KAWAJI T, Shiomi H, Bao B, Hojo S, et al
    Intracardiac energy inefficiency during atrial fibrillation rhythm with heart failure: Assessment by echo-vector flow mapping.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00392.
    >> Share

  337. DURAN A, Ventura HO
    The value of frequent objective risk assessments in heart failure management.
    Int J Cardiol. 2023 Mar 6:S0167-5273(23)00333.
    >> Share

  338. MOHEBI R, Liu Y, Murphy SP, Gaggin HK, et al
    Clinical profiling of end-stage heart failure with preserved ejection fraction: The National Readmission Database.
    Int J Cardiol. 2023 Mar 2:S0167-5273(23)00269.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016